How we move is an excellent indicator of overall health. When we feel good, we move around continually. When we’re in pain, we reduce our physical activity. This observation might seem trivial, but it has led to an original approach for evaluating chronic pain…
Long duration, controllable drug delivery is of wide interest to medical researchers and clinicians, particularly those seeking to improve treatment for patients with chronic pain or to prevent cancer recurrence after surgery…
A small study published online in the Journal of NeuroInterventional Surgery shows that a technique in which highly concentrated beams of radiation are used, known as Cyberknife, can relieve the stabbing pain of the facial nerve condition trigeminal neuralgia…
A 76-year-old man suffering from agonizing post-stroke shoulder pain for more than ten years is now pain-free, thanks to the world’s first implantation of an investigational pain therapy device from SPR™ Therapeutics…
A diagnostic tool that yields an objective physiological assessment of whether someone is in pain, as opposed to relying on self-reported measures, is being developed by researchers at the Stanford University School of Medicine in Palo Alto, California…
Researchers from the Stanford University School of Medicine have taken a first step toward developing a diagnostic tool that could eliminate a major hurdle in pain medicine - the dependency on self-reporting to measure the presence or absence of pain. The new tool would use patterns of brain activity to give an objective physiologic assessment of whether someone is in pain…
Zyga Technology, Inc. announced that the first European patients were enrolled and treated in its GLYDER Facet Resurfacing System Clinical Study. The purpose of the GLYDER clinical study is to evaluate the safety and effectiveness of the GLYDER device in patients with a history of facet pain demonstrated by treatment history and diagnosis as a baseline…
Anesthesiology researchers have shown that a device approved by the Food and Drug Administration to reduce the risk that patients will recall their surgery does not lower the risk of the problem, known as intraoperative awareness, any more than a less expensive method. The new study, published Aug…
BellaNovus Development Company LLC, a medical design and manufacturing company, today announced its launch of the Ouchless™ Needle Collection. The devices provide doctors and other clinicians an innovative alternative to numbing creams and ice currently used to minimize localized pain resulting from cosmetic injectables, such as Botox® and dermal fillers…
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced the Australian market launch of the Epiducer(TM) lead delivery system for neurostimulation therapy for the management of chronic pain…